When a gene produces too much protein, it can have devastating consequences on brain development and function. Patients with an overproduction of protein from the chromodomain helicase DNA binding (CHD2) gene can develop a rare and severe neurodevelopmental disorder that renders them wheelchair-bound, nonverbal and with profound intellectual delays.
Pfizer considers divestiture of hospital drugs business
The unit was established following Pfizer’s acquisition of Hospira in 2015. Credit: Pfizer. Pfizer is currently assessing the potential divestiture of its hospital drugs unit,
November 13, 2024